Skip to main content

GOLDMAN SACHS GROUP INC

Position in PYXS — Pyxis Oncology, Inc.

CIK 886982 NEW YORK, NY

Position in PYXS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$138,159
+$69,656 QoQ
Shares Held
45,900
-2.2% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 76 holders
Holding Since
Jun 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PYXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. PYXS ranks #324 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PYXS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $138,159 45,900
2026-03-31 $68,503 46,920
2025-12-31 $99,066 86,145
2025-09-30 $278,507 125,454
2025-06-30 $246,701 224,274
2025-03-31 $157,612 160,830
2024-12-31 $288,135 184,702
2024-09-30 $510,614 139,132
2024-06-30 $388,090 117,248
2024-03-31 $1,434,303 336,691
2023-06-30 $117,693 45,974
2023-03-31 $142,050 35,424
2022-06-30 $30,659 12,882